SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " utica " 445 found 🔀 AI-powered Shuffle
Hometown 'Voice' Sofronio Vasquez to Release New Album July 10
Utica's hometown "Voice" Sofronio Vasquez is gearing up to launch a new album.
Subanutica 2 major update adds the ability to shoot fish
To kill fish or not to kill fish, that is the question
Subnautica 2's First Big Update Finally Lets You Fight The Fish
Adaptive Measures, releasing July 8, will also add a sprint, better docking, and more Biomod slots
Subnautica 2's first proper update is coming tomorrow, bringing in much needed creature behaviour changes and more
Plus, you'll have an easier time with biomods in the early game.
Vertex to buy Crinetics in $10 billion deal
Vertex Pharmaceuticals will buy Crinetics Pharmaceuticals for a total equity value of about $10 billion, the companies said on Monday.
Western Town Library plans free July programs
Western Town Library will host free July events including a magic show, Oneida Carry history presentation and the Utica ZooMobile.
CVS Health Corporation (CVS) Shares Up Significantly After Jim Cramer Said He Was Looking For A Good Year
We recently published Jim Cramer’s Biggest Winners to Buy: Top 20 AI & Other Stocks He Got Right in 2026. CVS Health Corporation (NYSE:CVS) is one of the stocks discussed by Jim Cramer. Pharmaceutical retailer CVS Health Corporation (NYSE:CVS) has become one of Cramer’s top stocks in the sector. Throughout this year, the CNBC TV […]
Probi celebrates 35 years of science and a new chapter with Symrise
Together, the companies are creating new opportunities to accelerate research, expand innovation and bring new and exciting biotic solutions to customers and consumers around the world
Krafton settles with Subnautica 2 developer after drawn-out dispute over $250 million
The battle is over.
Subnautica 2 studio Unknown Worlds' CEO resigns as Krafton agrees to pay $250m bonus
Krafton has settled its lawsuit with the former leadership team of Subnautica 2 developer, Unknown Worlds, and agreed t…
Krafton Agrees to Pay ‘Subnautica 2’ Bonuses as Developer’s CEO Resigns
After being fired over a $250 million payout dispute and then reinstated, Unknown Worlds Entertainment boss Ted Gill is leaving again
Anthropic debuts AI-driven pharma R&D tool, Claude Science
Anthropic launches Claude Science as big tech companies increasingly eye expansion in the wider healthcare and life sciences space.
Peptides are the latest US health craze. But what exactly are they?
While peptides are taking the health and wellness category by storm for various use cases, what exactly are they? Leerink Partners senior research analyst Michael Cherny helps break down what a peptides are, how people are choosing them for personal health and recovery reasons, and who the biggest winners in consumer pharmaceuticals could be if their popularity continues to grow.
Indy economic development leaders visiting Switzerland on trade trip
The trip will involve meetings with leaders in the life sciences, biotechnology and pharmaceuticals, medical technology, digital heath and advanced manufacturing sectors.
Databricks and Nvidia Launch Genesis Workbench for AI Scientists
AI is becoming an increasingly important tool for drug discovery. However, for many pharmaceutical and biotech companies, the challenge isn’t finding more powerful models. It’s getting existing models to work […]
Efzimfotase alfa demonstrated improvements in bone health in treatment-naïve pediatric patients with hypophosphatasia achieving median difference of 1.67 vs placebo in RGI-C Score at week 25 in MULBERRY Phase III trial
Positive results from the MULBERRY Phase III trial showed that efzimfotase alfa (ALXN1850), an investigational enzyme replacement therapy, demonstrated a statistically significant and clinically meaningful improvement in bone health in children (2 to
'Drag Race' star reveals queen dropped out of 'All Stars 11'
Jasmine Kennedie revealed to EW that 'Drag Race' queen Utica dropped out of 'All Stars 11' before filming began — and Utica responds in an exclusive statement to EW.
Scientists measure hidden quantum forces that could power a new generation of pharmaceutical drugs
It's one thing to design a pharmaceutical drug. It's another to know if and why it actually works; not on paper or in a computer model, but inside the chaotic world of living systems, where proteins twist ...
Scientists measure hidden quantum forces that could power a new generation of pharmaceutical drugs
Researchers invent a laser technique that reveals the hidden forces shaping proteins, advancing a future of precision medicine engineered with quantum precision.
This health data provider could benefit as AI reshapes drug research
Harvey Stober, senior equity analyst and correspondent at CNBC, explains why this healthcare company could benefit from artificial intelligence reshaping the drug industry thanks to its treasure trove of data.
Utica City Pools, Splash Pads and Playgrounds Open for Summer
Families can now enjoy pools, splash pads and playgrounds across the City of Utica for the summer season.
Utica ballpark to host its first music festival
The professional baseball league operator is bringing another entertainment option and revenue stream to the ballpark.
Scott Lowe, researcher: ‘Governments must fund science. Pharmaceutical companies want to help, but they also want to make money’
The geneticist speaks with EL PAÍS about the advances and challenges in the field of cancer research
After 27 Years, Utica Zoo Is Retiring 'Brewfest'
Utica Zoo’s popular Brewfest fundraiser will not take place this year after running for 27 years.
Our New Study Shows That The Science Of Cannabis And Sleep Extends Beyond THC (Op-Ed)
“We found that the strongest evidence for improving sleep was associated with cannabidiol (CBD), cannabinol (CBN) and combinations of the two—but not primarily THC.” By Andrea Efre, University of South Florida College of Nursing The cannabis sleep market represents a shift away from traditional pharmaceuticals toward a natural alternative. Historically, cannabis products marketed for sleep […]
Hundreds help kick off first ever Utica Unity Weekend
Face painting, cotton candy ring toss and more greeted children at Carnival Day the Utica Recreation Center on Saturday — and that was just one of the three days dedicated to Utica Unity Weekend, hosted by the city Youth Bureau and several community organizations.
ECRD 2026: Europe’s rare disease bottleneck is funding rather than science
Derisking assets to attract capital and rethinking funding models should be key priorities for Europe to retain its research pipeline.
Bayer appoints Reinhard to president of radiology business
Bayer announced that Dr. Jost Reinhard will be appointed president of the radiology business within Bayer’s Pharmaceuticals Division.
Astronauts Could Grow Their Own Medicines in Space Using Plants
The pharmaceutical cabinet of the future might look a lot like a garden.
US: Global Health Aid Tied to Harmful Conditions
The United States government is conditioning lifesaving health assistance on broad access to surveillance data and extractive rights to pathogen samples and data for pharmaceutical development.
Scientists achieve the first total synthesis of a complex alkaloids isolated from plant
Monoterpenoid indole alkaloids (MIAs) are plant-derived molecules with unique pharmaceutical potential, but their highly complex and intricate structures make them difficult to produce in the laboratory. Now, researchers from Japan have developed a new strategy that enables the total synthesis of bisleuconothine A and bousigonine B, two biologically relevant oligomeric MIAs. Their findings lay the foundation for further studies of this family of molecules. Monoterpenoid indole alkaloids (MIAs) are plant-derived molecules with unique pharmaceutical potential, but their highly complex and intricate structures make them difficult to produce in the laboratory. Now, researchers from Japan have developed a new strategy that enables the total synthesis of bisleuconothine A and bousigonine B, two biologically relevant oligomeric MIAs. Their findings lay the foundation for further studies of this family of molecules.
U.S. Supreme Court sides with generic drug maker for severe hypertriglyceridemia agent icosapent ethyl
The decision clears the way for Hikma Pharmaceuticals' sale of icosapent ethyl in the U.S. market.
E-bike safety; lung cancer treatment and prevention; keeping CMA Festival attendees safe; plus other stories with Vanderbilt Health sources
WKRN News 2 interviewed Jeffrey Upperman, MD, FACS, Professor and Chair of the Department of Pediatric Surgery and Surgeon-in-Chief of Monroe Carell Jr. Children’s Hospital at Vanderbilt, about e-bike related injuries following the recent death of a Brentwood High student and a proposal to require safety training before students could ride a bike on a school campus in Williamson County. Fabien Maldonado, MD, MSc,Professor of Medicine and Thoracic Surgery, was on WTVF News Channel 5‘s live studio show, “Openline,” with host Ben Hall, to discuss lung cancer, treatment and prevention. WSMV’s “Today In Nashville” program hosted Vanderbilt LifeFlight paramedic/flight nurse practitioner Tony Smith to talk about safety for the CMA Festival. The New York Times reporter Carl Zimmer interviewed James Crowe, MD, Director of the Vanderbilt Center for Antibody Therapeutics, for a story about the race to find vaccines and treatments as Ebola spreads. The Vanderbilt Health News release about the pilot clinical trial conducted by Vanderbilt Health and Cumberland Pharmaceuticals Inc., that confirms the safety of ifetroban and supports the further development of the drug to prevent cancer metastasis, was picked up by Reuters, Stock Titan,and others. Women We Admire has named Lee Ann Liska, President and Chief Operating Officer, to its list of top women leaders of Nashville for 2026. Radiology Business, Aunt Minnie, Bioengineer, and Imaging Technology News covered the study from Consuelo Wilkins, MD, MSCI, the Mildred Thornton Stahlman Professor in Rural Health and professor of Medicine in the Division of Geriatric Medicine, that found Black and Hispanic people, while known to be far more apt to have dementia, are significantly less apt than other racial and ethnic groups to show Alzheimer’s pathology on brain scans. STAT News interviewed Deva Sharma, MD, Transfusion Medicine & Hematology-Oncology, for a story about more patients requesting unvaccinated blood and what it means for the medical system at large. Yahoo! Health reporter Korin Miller interviewed Gitanjali Srivastava, MD, Director of Obesity Medicine, for a story about how semaglutide and tirzepatide compare. William Schaffner, MD, Professor of Preventive Medicine, was quoted by several news outlets about public health issues, including: NBC News (new COVID vaccinations); Medscape (pneumonia and sepsis); and CNN (protection from contagious viruses). Shelbyville Times-Gazette is repurposing Jessica Pasley’s July 2025 Vanderbilt Health News story on tick-borne illnesses as a front-page story.
Special Olympic Summer Games Coming to Utica
Trucks loaded with equipment are arriving at Utica University as preparations begin for the New York State Special Olympics.
UNT Health Fort Worth’s new pharmaceutical sciences program comes at ‘critical time’ for region
Starting this fall, UNT Health Fort Worth will offer a new pharmaceutical sciences PhD program — the first of its kind in North Texas. The school said the new program could help address workforce needs as the life sciences and research and development industries continue to grow in the region.
UNT Health Fort Worth’s new pharmaceutical sciences program comes at ‘critical time’ for region
Starting this fall, UNT Health Fort Worth will offer a new pharmaceutical sciences PhD program — the first of its kind in North Texas. The school said the new program could help address workforce needs as the life sciences and research and development industries continue to grow in the region.
UNT Health Fort Worth’s new pharmaceutical sciences program comes at ‘critical time’ for region
Starting this fall, UNT Health Fort Worth will offer a new pharmaceutical sciences PhD program — the first of its kind in North Texas. The school said the new program could help address workforce needs as the life sciences and research and development industries continue to grow in the region.
Everwell Health highlights science-backed ingredients for functional beverages at BevNET Live 2026
Everwell Health will showcase its “Ingredients for Life” portfolio at BevNET Live in New York City from June 10–11
Eli Lilly's top dealmaker says don't be surprised to see more M&A that pushes Lilly into new areas
Eli Lilly's new top dealmaker explains how the company changed its approach to M&A now that it's the most valuable pharmaceutical company in the world.
Subnautica 2 Is Finally Getting On Top Of Its Violence Problem
Hotfix 3 finally introduces some balance to the game's most irritating predators
Servier to buy Edgewise's muscular dystrophy business for $2.65bn
Servier has signed an agreement to acquire Edgewise Therapeutics’ muscular dystrophy business in a deal valued at up to $2.65bn.
Servier to Acquire Edgewise Therapeutics' Muscular Dystrophy Business
/PRNewswire/ -- Servier, an independent international pharmaceutical group governed by a foundation, today announced that it has entered into an agreement to...
Subnautica 2 publisher Krafton now forced to pay $250m earnout to Unknown Worlds developers after more than 4m units sold
After a stellar early access launch, Subnautica 2 publisher Krafton will have to pay $250m to Unknown Worlds' leadership as ordered by law.
Nuvalent Announces Key Program and Business Updates, Strengthening Foundation for Global Leadership in ROS1- and ALK-positive NSCLC
/PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically...
Three Monarchs Earn Prestigious National Science Foundation Graduate Research Fellowships
By Robyn Sidersky Three recent Old Dominion University graduates are preparing to tackle some of society’s biggest scientific challenges, from developing sustainable pharmaceuticals to restoring wetlands and advancing regenerative medicine, with help from one of the nation’s most prestigious graduate fellowships.
Beyond DHA content: The emerging science of brain lipid transport
The future of brain omega-3 may be about smarter transport, not just higher doses
Croma Skincare – Where Science Meets Skin
LEOBENDORF, Austria, May 26, 2026--With Croma Skincare, Austrian family-owned company Croma Pharma translates decades of expertise in aesthetic medicine into a modern skincare line designed for everyday results. Rather than following short-lived trends, Croma focuses on scientifically proven ingredients and pharmaceutical-grade formulations that deliver visible performance while fitting seamlessly into daily routines.
Leading the shift in liquid dietary supplements through science and delivery
Uroš Gotar, Chief Innovation Officer at TOSLA, explains how scientific validation, flavour engineering, and liquid delivery are shaping the next phase of growth in nutraceuticals
Global Mitochondrial Health Summit 2026: How nutraceuticals power cellular energy for longevity
Mitochondrial health is now recognized as vital for overall well-being and longevity. Leading clinicians, researchers, and educators on the emerging science behind the cellular powerhouse will be meeting on June 26 at the inaugural Global Mitochondrial Health Summit, hosted by Kaneka Ubiquinol.Ahead of the event in Sydney, Australia, Nutrition Insight speaks with Dr. Kazunori Hosoe, scientist and researcher at Kaneka Corporation, about advancements in mitochondrial science, gaps in nutraceutical products, and how the industry can communicate complex science with consumer-friendly messaging.
Munson closes The Met: Live in HD season with 'El Último Sueño de Frida y Diego'
UTICA — Munson is closing its season of The Met: Live in HD, a series of live cinema transmissions, with American composer Gabriela Lena Frank’s first opera, “El Último Sueño
Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification
Anavex Life Sciences Corp. (“Anavex” or the “Company”)(Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for central nervous system (CNS) disorders, today announced it received anexpected delinquency notification letter (the “Notice”) from the Listing QualificationsDepartment of The Nasdaq Stock Market LLC (“Nasdaq”) on May 20, 2026.
World Health Assembly endorses resolution on precision medicine
At the Seventy-ninth World Health Assembly, Member States endorsed a new resolution on Precision medicine: a path towards targeted, personalized and equitable care, taking an important step towards advancing precision medicine as part of efforts to strengthen equitable, effective and sustainable health systems. Precision medicine refers to the use of clinical, molecular, genomic and other health data to inform prevention, diagnosis and treatment, taking into account variability while applying appropriate ethical and legal safeguards. When integrated responsibly into health systems, precision approaches can improve outcomes across different disease areas and across the life course – from cancer and rare diseases to infectious diseases, maternal, newborn and child health, mental health and noncommunicable diseases. The resolution reflects rapid advances in genomics, diagnostics, data science and digital health, alongside widening global inequities in access to these innovations. Many populations – particularly in low- and middle-income countries – remain underrepresented in data and research, limiting the public health impact of precision medicine and risking the widening of health disparities if action is not taken now. "Precision medicine is not an aspirational idea for health delivery in the future – it is already transforming lives across the world. But its benefits remain out of reach for too many and the research driving progress is concentrated in high income countries. This WHA resolution gives global health leaders, ministries of health, and WHO a clear mandate: to act. From infant screening to setting up genomic databases WHO will work with countries to bring about the power of these innovations." Dr Meg Doherty, Director Science for HealthThrough the resolution, Member States commit to developing and strengthening national policies, infrastructure, workforce capacity and governance frameworks to support the safe, ethical and equitable integration of precision medicine into health systems, aligned with universal health coverage. This includes promoting affordability, ensuring inclusive research and data systems, strengthening regulation and data governance, and fostering collaboration across sectors and regions.WHO is requested to provide technical and normative support, review and coordinate existing guidance, facilitate global and regional collaboration, and develop a Global Strategy on Precision Medicine to guide equitable and context‑appropriate implementation. WHO stands ready to support Member States through tools such as a country maturity model for countries to self-assess capacity in implementing precision medicine depending on their context. In the immediate term WHO will map all existing guidance and frameworks and host extensive consultations with interest holders globally.By placing equity, inclusion and public value at the centre of precision medicine, the resolution reinforces WHO’s commitment to ensuring that scientific advances benefit all people, everywhere, and that no one is left behind in the next era of health innovation."By uniting people-centered healthcare with innovation, precision medicine has the potential to transform lives. This resolution helps ensure those advances serve the shared goal of health for all." Dr Sylvie Briand, Chief Scientist For further information please visit the Health Topic: Genomics
The Science Behind the Quest for a Non-Peptide Oral Weight Loss Drug
Not only does it have a tongue-twisting name, “orforglipron” has a complex molecular structure that made its synthesis very challenging. A massive effort by chemists at the Eli Lilly pharmaceutical
Health Care Roundup: Market Talk
Find insight on AstraZeneca, Sino Biopharmaceutical, ConvaTec and more in the latest Market Talks covering the Health Care sector.
Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference Call
NORWOOD, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a clinical-stage company focused on devel...
Subnautica 2 dev apologises for telling combat-seeking players to "go play Sons of the Forest or something"
A desire for self-defence in the underwater survival game comes from some mechanics not working well enough yet, Subnautica 2 developer Unknown Worlds explains.
Subnautica 2 Devs Respond To Combat Debate, Promise Changes
Unknown Worlds has promised 'improvements to creature behavior and player mitigation tools,' but no knife
It's not you, would-be Subnautica 2 fish murderers, it's our creature encounters not feeling "fair, readable, and engaging" enough, say Unknown Worlds
Subnautica 2's devs have pledged to make creature run-ins "feel fair, readable, and engaging" in an open letter responding to calls for killable fish.
Unknown Worlds / A Letter To The Community From The Subnautica 2 Team
A letter from the Subnautica 2 team to the community, addressing some key feedback since launch.
Subnautica 2 Dev Gives Players Hope Amid the Game's First Hot Topic Following Launch
Fresh from its huge early access launch, underwater survival and crafting adventure game Subnautica 2 has sparked a significant debate among fans: to kill or not to kill the fish.
The Subnautica 2 fish self-defence debate rages on, as the game’s non-violent themes clash with player desire to fend off underwater threats
Unknown Worlds has stayed true to its oceanic pacifism themes, while the realities of living with dangerous animals has some players frustrated.
Kyowa Hakko highlights Cognizin citicoline’s science-backed cognitive health benefits
Kyowa Hakko USA is spotlighting citicoline’s benefits for cognitive performance and long-term brain health through multiple complementary mechanisms. The supplier will exhibit its citicoline ingredient Cognizin at this week’s Complementary Medicines Australia (CMA) Innovation Day 2026 in Sydney, Australia (May 21). CMA Innovation Day is one of Australia’s annual industry gatherings for the nutraceuticals supply chain, showcasing the latest innovations shaping the market for vitamins, minerals, and supplements in Australia and the Asia-Pacific region.
Subnautica 2's Early Access roadmap is here
Subnautica 2 developer Unknown Worlds has outlined what to expect in the early to mid-term of its early access release.
Subnautica 2 Xbox players could eventually test new features early like Steam players
Unknown Worlds would love for Xbox players to test Subnautica 2 updates before they launch
Citius Oncology, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
/PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology" or the "Company") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc....
Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
/PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated to the development and...
"I cannot condone piracy, but I get why people do" - Subnautica 2 lead designer airs frustration at 'flagrant' pirates
This comes as Subnautica 2 makes a massive splash on Steam and Xbox, boasting over two million copies sold.
Unknown Worlds / Subnautica 2 Early Access Roadmap
We want to share a few more details about what you can expect from Subnautica 2 in our first Early Access roadmap.
Subnautica 2 already has huge concurrent player counts and has swum to one million sales already
Within its first 24 hours live, Subnautica 2 has made a dominating start on Steam, though console figures remain a mystery.
Sure Seems Like Subnautica 2’s Developers Are Going To Get Their $250 Million Bonus
Perhaps the mostly costly example yet of why you should never take advice from ChatGPT
Subnautica 2 Lures In Nearly Half a Million Concurrent Players on Steam Within First Hour of Release
Subnautica 2 has attracted almost half a million concurrent players on Steam in its first hour of release.
Subnautica 2 Early Access Roadmap Sneak Peek
Unknown Worlds Entertainment has revealed a sneak peek at the upcoming early access roadmap for Subnautica 2.
Subnautica 2 has hooked me on an irresistible mystery
At the end of Subnautica 2's prologue, fear has already set in - and I haven't even reached its new ocean planet, Prote…
KFF Poll Finds That Most Adults Lack Confidence in Key Health Agencies to Act Independently — The Monitor
KFF’s latest Health Tracking Poll finds that confidence in the independence of key government health agencies overseeing food and drug safety and public health is low among the public and across partisans. Most of the public also share a distrust of agriculture, food, and pharmaceutical companies to act in the public’s best interest, compared with doctors and health care providers who are much more trusted among the public.
State honors Utica business owner at 'Dominicans in Albany'
Mohawk Valley Dominican business leaders, including Utica's Excellent Tape owner Oscar Martinez, recognized at annual "Dominicans in Albany," May 11.
Precigen Reports First Quarter 2026 Financial Results and Business Updates
Precigen, Inc. (Nasdaq: PGEN), a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients, today announced first quarter 2026 financial results and business updates.
Azitra, Inc. Announces Q1 2026 Results and Provides Business Updates
/PRNewswire/ -- Azitra, Inc. ("Azitra" or the "Company") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative...
Palatin Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing medicines that target the melanocortin receptor (MCR) system, today announced financial results for its fiscal third quarter ended March 31, 2026, and provided a business update.
Alto Neuroscience Reports First Quarter 2026 Financial Results and Recent Business Highlights
MOUNTAIN VIEW, Calif., May 13, 2026--Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today reported financial results for the quarter ended March 31, 2026, and highlighted recent progress across its pipeline of clinical-stage product candidates.
Free Summer Programs for Kids in Utica
Kids in the City of Utica have a range of free summer programs to choose from, including sports clinics, swim lessons and playground activities.
Health Care Roundup: Market Talk
Find insight on the deal between Hengrui Pharmaceuticals and Bristol Myers Squibb and more in the latest Market Talks covering the health care sector.
Bayer Profit Up On Seed Business But Glyphosate Sales Struggle
German agrichemical and pharmaceutical giant Bayer reported a bump in first-quarter profit on Tuesday, driven by its agricultural business, even as sales of controversial glyphosate-based weedkillers struggled.
Crust Kitchen and Bar Opens New Location in Utica
A popular restaurant known for its crafted salads, sandwiches and soup has opened a new location in Bagg's Square.
Avalere Health expands to Japan with a full-service Advisory, Medical, and Marketing offering, led by industry veteran Junji Yokokawa
Avalere Health, a global strategic partner for the healthcare industry, today announces the launch of its Japan office. The move marks a significant expansion of Avalere Health's global footprint, and the launch of a new strategic offering is designed to support Japanese biopharmaceutical companies end-to-end across the product lifecycle.
Xbox gets another 30 new games next week
Over the next seven days, Subnautica 2, Outbound, Directive 8020, and 27 more new games launch across Xbox Series X|S, Xbox One, and PC.
New Subnautica 2 gameplay teaser has just dropped and if you weren't excited before, you will be now
We're just days away from returning to the beautiful briny in Subnautica 2, and to celebrate, we've been treated to an …
Germany’s Healthcare Reforms Herald More Pain for Big Pharma
Donald Trump’s push to bring down drug prices in the US has rattled the world’s leading pharmaceutical companies. Now, they’re confronting a new menace as Germany seeks to plug a ballooning deficit in its public health-insurance funds.
IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights
Advancing next-generation γδ T cell engager platform with initial animal data expected in 2026Reported glioblastoma (GBM) data showing ~97% improvement in progression-free survival vs. standard-of-care; updated median overall survival (mOS) data to be presented at ASCO 2026Hosting R&D Day on May 21, 2026 in New York City NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies and γδ
Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update
/PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and...
UToledo Unveils Online Master’s Degree Focused on Health Outcomes and Analytics
The 100% online graduate program equips healthcare professionals with cutting-edge, in-demand analytical skills.
6 Broadway Shows Coming to Stanley Theatre for 2026-2027 Season
Broadway Theatre League of Utica is bringing six major Broadway shows to The Stanley Theatre for its 2026–2027 Adirondack Bank Season.
White House says Trump's deals with pharmaceutical companies offer billions in savings
WASHINGTON (AP) — White House economists estimate that President Donald Trump’s deals with pharmaceutical companies to drop some of their U.S. prescription drug prices to what they charge in other countries could save $529 billion over the next 10 years. The analysis obtained by The Associated Press includes the first economy-wide projections behind a policy at the core of Trump’s pitch to voters going into November’s midterm elections for control of the House and Senate.
Business Owner Wins Veteran Business Award in Utica
A local business received special recognition as part of National Small Business Week.
Coming to Xbox Game Pass: Forza Horizon 6, Mixtape, Subnautica 2, and More
Coming to Xbox Game Pass: Forza Horizon 6, Mixtape, Subnautica 2, and more!
Mohawk Valley high school sports schedule and scores for May 4-10
Results and highlights for Mohawk Valley high school sports competition during the week of May 4-10, 2026.
Global Health & WASH: May 2026 Funding Opportunities (14 new opportunities!)
The May update for Global Health & WASH brings new calls that cluster around three distinct shifts: LMIC research leadership moving from funder encouragement into a hard eligibility constraint, pharmaceutical and corporate-linked funders running structurally independent education and use-inspired research portfolios at substantial scale, and AI adoption shifting decisively from speculative tool to operational capability across health and WASH systems alike. In LMIC Research Leadership as Eligibility, Not Encouragement, Wellcome anchors the dominant signal of the month with three separate major calls that all require or strongly center LMIC leadership in their basic eligibility architecture. Wellcome’s ESIC Hubs (£1.5-£1.9M per hub over 3-5 years) explicitly requires an LMIC-based lead applicant, treating Global South leadership as a design constraint rather than a participation goal. Wellcome’s Infectious Disease Clinical Trial Development Award funds transdisciplinary teams whose lead must be a mid-career or established researcher based at an organization in Africa, South Asia, or Southeast Asia. Wellcome’s larger Infectious Disease Clinical Trial Award (£1M-£8M for optimizing licensed interventions) requires the administering organization to be in eligible LMIC regions and at least 50% of applicants based there. Around Wellcome, the same pattern shows up at smaller scale and across funders: CHINNOVA channels $1M into West and Central African research institutions for climate-health work; IBRO’s Neuroscience Training Grants explicitly tier ceilings by region of residence with Africa receiving the highest amount ($5,000); IHME’s GBD Emerging Researcher Award reserves at least one of its two annual awards for an LMIC researcher; Sidaction’s HIV Cure call funds research teams across France, the Netherlands, and eligible African countries with a minimum two-country collaboration requirement. Taken together, these calls signal a meaningful shift in how research equity is being operationalized — not as encouragement language at the bottom of a call, but as a structural feature of who can lead, where the work must be administered, and what proportion of the team must be regionally rooted. In Pharma-Funded Independent Medical Education and Use-Inspired Research, the lineup this month is unusually deep. Pfizer alone runs four parallel calls under independent education and quality improvement frameworks: a Migraine and Women’s Health RFP (200K x 2-year, $500K pool), Migraine IME ($200K, $1M pool), JAK Inhibitor evidence-based education ($100K), and Maternal Vaccination HCP Education in Saudi Arabia ($75K), plus a separate Pediatric Pneumococcal Surveillance research call in Saudi Arabia ($400K per project). Novo Nordisk Foundation runs four parallel calls of its own at substantial scale: Infectious Diseases Catalyst Grants (DKK 60M pool, up to DKK 7M collaborative), Non-Diabetic Endocrinology Collaborative Grants (DKK 53M pool, DKK 5-10M per project), Pioneer Innovator Grant Health (DKK 1.1M), and Distinguished Innovator Grant Health (DKK 6.8M). LEO Foundation deploys DKK 2-4M per project for dermatology research excellence. Pfizer’s framing across calls deliberately separates the funding from product promotion, emphasizing measurable practice-relevant change and structural distance between scientific outputs and commercial activity. Novo Nordisk’s “use-inspired” hard filter pushes researchers toward a credible translation pathway from mechanism to deployable tool. The pattern: industry-aligned funders are running structurally independent portfolios at meaningful $ that fund implementation evidence, not promotion. In AI as Operational Capability, Not Speculation, several calls this month explicitly treat AI adoption as a near-term operational question with real evidence and governance requirements, rather than a speculative trend to be watched. Wellcome’s ESIC Hubs frames AI as “the accelerator” for evidence synthesis, asking hubs to translate technical innovation into adoption-ready workflows that can match real-world policy timelines. UNICEF Venture Fund’s new Climate Tech for Children’s Health call funds for-profit startups deploying AI, machine learning, and blockchain in low-resource environments, with a strict requirement that solutions must already have a working prototype with promising pilot results. The Water Research Foundation has launched two simultaneous AI calls treating reproducibility, cybersecurity guardrails, and human-in-the-loop deployments as core design constraints rather than nice-to-haves: one on GenAI and Agentic AI in water utilities ($200K), one on alternatives to water shutoffs that explicitly screens for implementation economics evidence. Nordic Innovation’s quantum technology call (NOK 4.5M) extends the same logic into life science and healthcare, demanding consortium-stage projects mature enough to test with real users. TEF-Health offers €300K in subsidized testing infrastructure for European healthcare AI and robotics SMEs. The pattern: funders are converting AI pilots into playbooks, requiring transfer evidence and risk controls before AI can move from experimentation to sector-wide operational practice. For LMIC-based researchers in infectious disease or evidence synthesis, the three Wellcome calls together represent the deepest concentration of LMIC-led research capital in recent memory — pair the Infectious Disease Clinical Trial Development Award (£200K, deadline May 19) as a strategic pipeline feeder into the larger Infectious Disease Clinical Trial Award (£1-£8M, deadline June 2), since the development award functions explicitly as a track into the larger trial scheme. For Nordic researchers, the four Novo Nordisk Foundation calls plus LEO Foundation and Nordic Innovation Quantum represent ~$30M in regional research capital this cycle, all with deadlines clustered in May-August. For WASH practitioners, the three Water Research Foundation calls together (each up to $200K) are a cluster worth reading across — one on AI deployment, one on shutoff alternatives, one rewarding applied innovation — and the strongest applicants will articulate how their work bridges utility operations to policy-relevant evidence. For US-based clinical researchers and educators, the four Pfizer calls plus the APF Portfolio’s 80+ programs form an unusually accessible recurring pipeline; APF’s prohibition on indirect costs is a meaningful structural feature for early-career applicants whose institutions might otherwise absorb significant overhead. Snapshot of New Opportunities Total Estimated Funding Pool: $100 Million+ USD The grants are organized into three categories: Open Calls: Current grant and opportunities with a deadline. Grants are listed by closing date. 39 open opportunities- 14 new! Rolling Applications: current grant and opportunities with rolling applications (but it’s still best to submit as early as possible). 14 rolling opportunities- 1 new opportunity! Long term planning: Grants that have closed their current rounds, but are expected to open new windows. 4 long term opportunities! A quick tip for returning readers: if you want to jump straight to the newest additions, use CTRL F to search for “New!” and navigate quickly to the latest funding opportunities This post is for paid subscribers. This helps support the time and effort it takes to curate and organize these opportunities. Subscribe To keep this accessible to everyone who needs it, we’re happy to offer pay what you can rates. You can find more details here. Open Calls: Migraine Competitive Grant Program: Migraine and Women’s Health (Quality Improvement and/or Research RFP), Pfizer.*Closing soon!* Pfizer, in collaboration with the American Headache Society, is seeking independent quality improvement and research projects that close persistent gaps in migraine care for women across the United States. The funding logic centers on measurable, practice-relevant change: proposals should generate actionable evidence, tools, or system improvements that can be shared and used widely, not just within a single site. Priority areas span menstrual migraine and screening in women’s health settings, the role of hormonal fluctuations across the lifespan, sex-specific risk factors, comorbidities and quality-of-life burden, and disparities in outcomes by race, ethnicity, and socioeconomic status. The call is structured as a two-step competitive process with an initial Letter of Intent, with the strongest concepts expected to translate scientific insight into implementable improvements in diagnosis, management, and equity. Geographies: United States. Who can apply: U.S.-based organizations (not individuals), including professional schools, healthcare institutions, professional organizations, and other entities focused on healthcare improvement. Funding amount: Up to USD $200,000 total over 2 years; total pool USD $500,000. Targeted Sectors / SDGs: Health; Focus areas: migraine, women’s health, quality improvement, clinical research, menstrual migraine, health disparities. Deadline: LOI: May 5, 2026; Full proposal (by invitation): August 28, 2026. Learn more and apply here. This RFP rewards “shareable impact”: the most competitive submissions will pair rigorous methods with a clear plan for system uptake and dissemination beyond the originating institution. ReSSARC: Strengthening the Health Sector and Food Security in the Central African Republic (AID 013381/01/0) Call for Proposals, Italian Agency for Development Cooperation (AICS). *Closing soon!* AICS is seeking a limited set of high-capacity humanitarian partners to deliver an integrated package that stabilizes essential health services while reducing acute malnutrition and strengthening food security resilience in priority areas of the Central African Republic. The funder’s logic is explicitly nexus-based: proposals should meet urgent, life-saving needs while reinforcing local systems, coordination mechanisms, and community-level capacity so results persist beyond the emergency window. AICS emphasizes inclusion and protection outcomes, expecting gender-sensitive design and explicit measures for groups facing compounded vulnerability, including women, children under five, internally displaced people, and people with disabilities. The call also signals a localization pathway, encouraging stronger collaboration with national NGOs and balanced partnerships, alongside clear coordination with existing cluster and humanitarian actors to minimize duplication and improve coverage. Geographies: Central African Republic (Bangui, Ombella-Mpoko, Ouham, Ouham-Pende, Lim-Pende, Lobaye). Who can apply: Non-profit organizations registered with AICS, plus eligible non-profits without an office in Italy that have a pre-existing collaboration agreement with an AICS-listed organization. Funding amount: Total pool EUR €1,800,000; max EUR €800,000 (single applicant) or EUR €1,000,000 (ATS). Targeted Sectors / SDGs: Health; Focus areas: malnutrition prevention and treatment, maternal and child health, community health services, food security and resilience, localization partnerships Deadline: May 5, 2026. Learn more and apply here. This call is structured to reward partners who can link frontline service delivery to system durability and localization, not just short-term coverage gains. Contracts for Innovation in drug and alcohol addiction healthcare, Innovate UK. *Closing soon!* Innovate UK, on behalf of the Office for Life Sciences Addiction Healthcare Goals program, is procuring R&D to accelerate innovations that can improve treatment outcomes, strengthen recovery, and reduce harm and deaths linked to drug and alcohol addiction. The competition is positioned as a market-facing readiness push: selected projects are expected to advance solutions toward later-stage validation, generate evidence of user acceptability and UK market fit, and map credible routes through regulatory and certification requirements. Innovate UK signals a preference for innovations that can be field-tested in relevant UK settings and progressed to TRL 6 or 7, with practical plans for commercialization after contract completion. This structure favors applicants that can execute most work in-house, co-develop with service providers and people with lived experience, and translate technical progress into deployable tools for addiction healthcare delivery. Geographies: United Kingdom. Who can apply: Single organizations of any size (including EU, EEA, or international) leading delivery, with most work and key deliverables carried out in the UK; subcontractors for specialist skills only. Funding amount: GBP £200,000–1.5 million per project (inclusive of VAT); Total pool: GBP £20 million (across two strands). Targeted Sectors / SDGs: Health; Focus areas: Mental Health, Health Systems Strengthening, Research & Development, Technology Access. Deadline: May 6, 2026 (11:00am). Learn more and apply here. This call uses procurement to pull near-market addiction innovations toward operational proof and adoption pathways in UK services.
Binghamton student finds her purpose inside and outside the classroom
Through a Binghamton University public health class and pharmaceutical internship, Camil Ventura ’26 found her calling.
Subnautica 2’s System Requirements Could Have You Diving for a Little Extra RAM Just to Reach 30FPS at 1080p
Unknown Worlds has revealed Subnautica 2's PC system requirements, and they may have players with older PCs diving for more RAM.
Apotex becomes the first Canadian‑based pharmaceutical company to receive Health Canada approval for a generic equivalent of Ozempic®
/PRNewswire/ - Apotex Inc. ("Apotex" or the "Company"), Canada's largest Canadian‑based global health company, today announced that Health Canada has approved...
Subnautica 2's early access system requirements are on the punishing side
Unknown Worlds and Krafton have released the minimum, recommended and ultra system requirements for Subnautica 2.